| Laboratorium Dr. G. Bichsel AG - Cardioplexol, Kardioplege Lösung | | 68015 | | 01 | | Cardioplexol | | Kardioplege Lösung | | B05XA16 | | Kardioplege Lösungen | | 31.08.2023 | | |
| | Composition | | I) Lösung A / 95 mL:magnesii sulfas heptahydricus 4 g, kalii chloridum 0.746 g, xylitolum 4.5 g, acidum citricum monohydricum, natrii hydroxidum corresp. natrium 345 mg, aqua ad iniectabile q.s. ad solutionem pro 95 ml.II) Lösung B / 5 mL:procaini hydrochloridum 0.3 g, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml, Corresp. procaini hydrochloridum 1.1 mmol. I) et II) corresp. Mischung aus Lösung A + Lösung B: magnesii sulfas heptahydricus 4 g, kalii chloridum 0.746 g, xylitolum 4.5 g, procaini hydrochloridum 0.3 g, acidum citricum monohydricum, natrii hydroxidum corresp. natrium 345 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 100 ml, Corresp. procaini hydrochloridum 1.1 mmol, magnesii sulfas heptahydricus 16.2 mmol, kalii chloridum 10 mmol, xylitolum 29.6 mmol. | | Packungsbestandteile | | I | | Kardioplege Lösung | | | | | | Principe actif | Concentr. |
|---|
| Potassium Chlorure | 0.746g / 95ml | | Magnesium Sulfate Heptahydrate | 4g / 95ml | | Xylitol | 4.5g / 95ml |
| | | | Agents auxilliaires |
|---|
| Acide Citrique Monohydre | | Sodium Hydroxide |
|
| II | | Kardioplege Lösung | | | | | | Principe actif | Concentr. |
|---|
| Procaïne Hydrochloride | 0.3g / 5ml |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | DDP | DDP | B | | Non |
|
|
